ILMN stock forecast
Our latest prediction for Illumina, Inc.'s stock price was made on the Feb. 3, 2020 when the stock price was at 293.41$.
In the short term (2weeks), ILMN's stock price should underperform the market by -0.72%. During that period the price should oscillate between -5.77% and +4.84%.
In the medium term (3months), ILMN's stock price should underperform the market by -0.66%. During that period the price should oscillate between -14.73% and +11.94%.Get email alerts
About Illumina, Inc.
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina segment, which serves customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. The firm's products include microarray scanners, sequencing reagents, and onsite training selector. Its services include sequencing and microarray services; proactive instrument monitoring; and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.
At the moment the company generates 3458M USD in revenues.
On its last earning announcement, the company reported a profit of 6.54$ per share.
The book value per share is 22.16$
Three months stock forecastFeb. 3, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|